CIK 0001759425 · Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831281555
- Phone
- 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 5,000 shares at an average $93.82 ($469,077)
- 4 Option exercise PRESIDENT AND COO acquired 16,988 shares (option exercise)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 30,000 shares at an average $95.84 ($2,875,103)
- 4 Option exercise Director acquired 3,977 shares (option exercise)
- 4 Option exercise Director acquired 3,977 shares (option exercise)
- 4 Open-market sale Director sold 3,977 shares at $100.00 ($397,700)
- 4 Option exercise Director acquired 3,977 shares (option exercise)
- 4 Planned sale Director sold 2,000 shares at $109.47 ($218,940)
- 4 Planned sale Director sold 2,000 shares at $96.90 ($193,800)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 7,287 shares at $91.98 ($670,243)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 7,287 shares at $91.98 ($670,243)
- 4 Planned sale Director sold 2,000 shares at $90.76 ($181,520)
- 4 Open-market sale PRESIDENT AND COO sold 16,515 shares at $91.98 ($1,519,015)
- 4 Open-market sale SVP, GLOBAL CONTROLLER sold 4,732 shares at $91.98 ($435,239)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 40,985 shares at $91.98 ($3,769,714)
Page 2 of 18 · 355 filings